机译:掺入VSV-G可产生融合型质膜囊泡,能够有效转移生物活性大分子和线粒体
Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China;
Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China;
Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China;
Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China;
Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China;
Shantou Univ, Coll Med, Lab Cell Senescence, Shantou 515041, Guangdong, Peoples R China;
Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Endocrinol, Shantou 515041, Guangdong, Peoples R China;
Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China;
Macro-biomolecules; Mitochondria; Plasma membrane vesicles; Rho0 cells; VSV-G;
机译:线粒体双层膜与MITO-Porter,线粒体融合囊泡之间的膜融合分析
机译:细胞工程与膜融合脂质体产生功能化的细胞外囊泡。
机译:人工细胞膜模拟纳米结构通过与活细胞质膜的融合相互作用促进有效的基因传递
机译:来自巨浆膜囊泡的支持等离子体膜平台研究膜蛋白
机译:活性区材料大分子的物理变化,可调节突触小泡膜与突触前膜的对接和融合以及从活性区去除融合的小泡膜。
机译:囊泡相关膜蛋白(VAMPs)和血浆膜t-SNAREs的融合融合-VAMP5为例外
机译:线粒体双膜与MITO-Porter,线粒体融合囊泡之间的膜融合分析